The effect of oral contraceptives on bone mass and stress fractures in female runners

Medicine and Science in Sports and Exercise

Volumn 39, Issue 9, 2007, Pages 1464-1473

  Cobb, Kristin L ^a,i   Bachrach, Laura K ^a   Sowers, Maryfran ^b   Nieves, Jeri ^c,h   Greendale, Gail A ^d   Kent, Kyla K ^e   Brown Jr , Byron W ^a   Pettit, Kate ^a   Harper, Diane M ^f   Kelsey, Jennifer L ^a,g  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c HELEN HAYES HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

Author keywords

Amenorrhea; Bone density; Calcium; Female athlete triad; Randomized trial

Indexed keywords

ETHINYLESTRADIOL PLUS NORGESTREL;

ADULT; AMENORRHEA; ARTICLE; BONE DENSITY; BONE MASS; BONE SCINTISCANNING; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENSTRUATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGOMENORRHEA; ORAL CONTRACEPTION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RUNNING; STRESS FRACTURE; WEIGHT GAIN;

ADOLESCENT; ADULT; AMENORRHEA; BONE DENSITY; CONTRACEPTIVES, ORAL, HORMONAL; ENERGY INTAKE; FEMALE; FRACTURES, STRESS; HUMANS; OLIGOMENORRHEA; RISK ASSESSMENT; RUNNING; UNITED STATES;

EID: 34548412675     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/mss.0b013e318074e532     Document Type: Article

References (30)

1. BARROW, G. W., and S. SAHA. Menstrual irregularity and stress fractures in collegiate female distance runners. Am. J. Sports Med. 16:209-216, 1988.
2. BENNELL, K., G. MATHESON, W. MEEUWISSE, and P. BRUKNER. Risk factors for stress fractures. Sports Med. 28:91-122, 1999.
3. BENNELL, K. L., S. A. MALCOLM, S. A. THOMAS, et al. Risk factors for stress fractures in track and field athletes. A twelve-month prospective study. Am. J. Sports Med. 24:810-818, 1996.
4. BRAAM, L. A., M. H. KNAPEN, P. GEUSENS, F. BROUNS, and C. VERMEER. Factors affecting bone loss in female endurance athletes: a two-year follow-up study. Am. J. Sports Med. 31: 889-895, 2003.
5. COBB, K. L., L. K. BACHRACH, G. GREENDALE, et al. Disordered eating, menstrual irregularity, and BMD in female runners. Med. Sci. Sports Exerc. 35:711-719, 2003.
6. CUMMING, D. C. Exercise-associated amenorrhea, low BMD, and estrogen replacement therapy. Arch. Intern. Med. 156:2193-2195, 1996.
7. DE SOUZA, M. J., and N. I. WILLIAMS. Beyond hypoestrogenism in amenorrheic athletes: energy deficiency as a contributing factor for bone loss. Curr. Sports Med. Rep. 4:38-44, 2005.
8. DRINKWATER, B. L., K. NILSON, S. OTT, and C. H. CHESNUT 3rd. BMD after resumption of menses in amenorrheic athletes. JAMA 256:380-382, 1986.
9. FREDERICSON, M., and K. KENT. Normalization of BMD in a previously amenorrheic runner with osteoporosis. Med. Sci. Sports Exerc. 37:1481-1486, 2005.
10. GARNER, D. M., and M. P. OLMSTED. Manual for Eating Disorders Inventory. Odessa, FL: Psychological Assessment Resources, Inc., 1984.
11. GIBSON, J. H., A. MITCHELL, J. REEVE, and M. G. HARRIES. Treatment of reduced BMD in athletic amenorrhea: a pilot study. Osteoporos. Int. 10:284-289, 1999.
12. HABERLAND, C. A., D. SEDDICK, R. MARCUS, and L. K. BACHRACH. A physician survey of therapy for exercise-associated amenorrhea: a brief report. Clin. J. Sport Med. 5:246-250, 1995.
13. HAREL, Z., and S. RIGGS. Transdermal versus oral administration of estrogen in the management of lumbar spine osteopenia in an adolescent with anorexia nervosa. J. Adolesc. Health 21:179-182, 1997.
14. HARTARD, M., C. KLEINMOND, A. KIRCHBICHLER, et al. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes. Bone 35:836-841, 2004.
15. HARTARD, M., P. BOTTERMANN, P. BARTENSTEIN, D. JESCHKE, and M. SCHWAIGER. Effects on BMD of low-dosed oral contraceptives compared to and combined with physical activity. Contraception 55:87-90, 1997.
16. HOCHBERG, Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802, 1988.
17. JAMIESON, M. A. Hormone replacement in the adolescent with anorexia and hypothalamic amenorrhea - yes or no? J. Pediatr. Adolesc. Gynecol. 14:39, 2001.
18. LINDBERG, J. S., M. R. POWELL, M. M. HUNT, D. E. DUCEY, and C. E. WADE. Increased vertebral bone mineral in response to reduced exercise in amenorrheic runners. West J. Med. 146:39-42, 1987.
19. LIU, S. L., and C. M. LEBRUN. Effect of oral contraceptives and hormone therapy on BMD in premenopausal and perimenopausal women: a systematic review. Br. J. Sports Med. 40:11-24, 2006.
20. MYBURGH, K. H., J. HUTCHINS, A. B. FATAAR, S. F. HOUGH, and T. D. NOAKES. Low BMD is an etiologic factor for stress fractures in athletes. Ann. Intern. Med. 113:754-759, 1990.
21. PRIOR, J. C., Y. M. VIGNA, M. T. SCHECHTER, and A. E. BURGESS. Spinal bone loss and ovulatory disturbances. N. Engl. J. Med. 323:1221-1227, 1990.
22. RICKENLUND, A., K. CARLSTROM, B. EKBLOM, T. B. BRISMAR, B. VON SCHOULTZ, and A. L. HIRSCHBERG. Effects of oral contraceptives on body composition and physical performance in female athletes. J. Clin. Endocrinol. Metab. 89:4364-4370, 2004.
23. SHAFFER, R. A., M. J. RAUH, S. K. BRODINE, D. W. TRONE, and C. A. MACERA. Predictors of stress fracture susceptibility in young female recruits. Am. J. Sports Med. 234:108-115, 2006.
24. WARREN, M. P., J. BROOKS-GUNN, R. P. FOX, et al. Persistent osteopenia in ballet dancers with amenorrhea and delayed menarche despite hormone therapy: a longitudinal study. Fertil. Steril. 80:398-404, 2003.
25. WARREN, M. P., K. K. MILLER, W. H. OLSON, S. K. GRINSPOON, and A. J. FRIEDMAN. Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on BMD in women with hypothalamic amenorrhea and osteopenia: an open-label extension of a double-blind, placebo-controlled study. Contraception 72:206-211, 2005.
26. WEAVER, C. M., D. TEEGARDEN, R. M. LYLE, et al. Impact of exercise on bone health and contraindication of oral contraceptive use in young women. Med. Sci. Sports Exerc. 33: 873-880, 2006.
27. WILLETT, W., and M. J. STAMPFER. Total energy intake: implications for epidemiologic analyses. Am. J. Epidemiol. 124:17-27, 1986.
28. WILLIAMS, N. I., D. L. HELMREICH, D. B. PARFITT, A. CASTONBALDERRAMA, and J. L. CAMERON. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J. Clin. Endocrinol. Metab. 86:5184-5193, 2001.
29. WOLMAN, R. L., P. CLARK, E. MCNALLY, M. G. HARRIES, and J. REEVE. Dietary calcium as a statistical determinant of spinal trabecular BMD in amenorrhoeic and oestrogen-replete athletes. Bone Miner. 17:415-423, 1992.
30. ZANKER, C. L., C. B. COOKE, J. G. TRUSCOTT, B. OLDROYD, and H. S. JACOBS. Annual changes of BMD over 12 years in an amenorrheic athlete. Med. Sci. Sports Exerc. 36:137-142, 2004.